ERBB2 and breast cancer: Other clinical trials are currently investigating DC vaccine in BC patients, such as HER2-pulsed DC vaccine (NCT02063724) an multiepitope DC vaccine (NCT00266110), and are also investigated in a neoadjuvant setting (NCT02018458)(NCT02061423)(NCT03387553).